Back

Efficacy and safety of PCSK9 inhibitors in lipid control in a follow-up at 6 months.

19 April 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Lipids Lipids EAPC Premium Access EuroPrevent 2018

About the speaker

Photo
Doctor Alfredo Chauca Tapia

University Hospital of Bellvitge, Barcelona (Spain)

9 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor A. Chauca Tapia (Barcelona, ES)
Presentation thumbnail
Mr M. Poudel (Bielefeld, DE)
Abstract Slides
Presentation thumbnail
Doctor R. Cadenas Chamorro (Madrid, ES)
Abstract Slides
Presentation thumbnail
Professor N. Mouine (Rabat, MA)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Lipids

The Event

Event poster

EuroPrevent 2018

19 April 2018 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources